Search for: "MERCK SHARP & DOHME"
Results 1 - 20
of 238
Sort by Relevance
|
Sort by Date
7 Mar 2024, 12:00 am
On 18 January 2024, in case C-367/21 (still no English version) the CJEU ruled again on the exhaustion of EU trade mark rights (following its five rulings of 17 November 2022 including C-175/21 Harman International Industries, C-224/20 Merck Sharp & Dohme, and C‑204/20 Bayer Intellectual Property). [read post]
5 Mar 2024, 10:23 am
Sanofi Pasteur and Merck Sharp & Dohme (the “petitioners”) challenged the validity of the ‘559 patent claims in five inter partes review (IPR) proceedings, arguing they were obvious over prior art references disclosing multivalent pneumococcal vaccines. [read post]
4 Feb 2024, 7:14 am
A noteworthy exception is the dispute between Merck Sharp & Dohme LLC (MSD) versus Spirig HealthCare AG (Spirig, a Stada subsidiary). [read post]
3 Jan 2024, 12:08 am
Guest post by Professor Yeo Tiong Min, SC (honoris causa), Yong Pung How Chair Professor of Law, Yong Pung How School of Law, Singapore Management University Merck Sharp & Dohme Corp (formerly known as Merck & Co, Inc) v Merck KGaA (formerly known as E Merck) [2021] 1 SLR 1102, [2021] SGCA 14 (“Merck”), noted previously, is a landmark case in Singapore private international law, being a decision of a full bench of the… [read post]
29 Aug 2023, 7:56 pm
Methods: We inputted all 36 published clinical vignettes from the Merck Sharpe & Dohme (MSD) Clinical Manual into ChatGPT and compared its accuracy on differential diagnoses, diagnostic testing, final diagnosis, and management based on patient age, gender, and case acuity. [read post]
14 Aug 2023, 5:03 am
(I will have to go away and read Merck Sharp & Dohme Corp v Merck KGaA (2021) 1 SLR 1102 properly.) [read post]
25 Jul 2023, 1:43 am
Merck Sharp & Dohme Corp). [read post]
16 May 2023, 7:33 am
See Merck Sharp & Dohme Corp. v. [read post]
16 May 2023, 7:33 am
See Merck Sharp & Dohme Corp. v. [read post]
16 May 2023, 7:33 am
See Merck Sharp & Dohme Corp. v. [read post]
28 Mar 2023, 4:46 am
In November 2020, the BRPTO rejected without further administrative appeal a patent application filed by Merck Sharp & Dohme (MSD) on January 8, 2009, after the applicant failed to respond to an office action and later to appeal the decision rejecting the application. [read post]
4 Mar 2023, 8:45 pm
Irving of Finnegan Henderson Farabow Garrett & Dunner, Sarah Hooson of Merck Sharp & Dohme, Krista Kostiew of Unilever, and Xiaoguang Michelle Gao of Eli Lilly and Company will guide patent counsel on recent trends and developments in patent practice; examine the Supreme Court, Federal Circuit, and PTAB cases from the past year; and discuss some of the key developments and strategies.... [read post]
13 Feb 2023, 2:40 pm
EU/1/15/1024 for pembrolizumab, granted to Merck Sharp & Dohme. [read post]
11 Feb 2023, 7:17 pm
MacAlpine of Finnegan Henderson Farabow Garrett & Dunner, and Sarah Hooson of Merck Sharp & Dohme will guide patent counsel on recent Orange Book developments; discuss Orange Book listing practices and the implications for patent prosecution, listing, and litigation; and examine contemporary thought about Form 3542 and pitfalls to avoid.... [read post]
27 Dec 2022, 4:33 pm
Merck Sharp & Dohme (C-119/22) made by the Finnish Market Court in February 2022 (see here for an English translation of the referring decision) and Merck Sharp & Dohme v. [read post]
25 Oct 2022, 8:30 am
Spanish anitrust agency Comisión Nacional de los Mercados y la Compentencia (CNMC) Tuesday fined US pharmaceutical company Merck Sharp and Dohme (MSD) 39 million euros for abuse of the market. [read post]
5 Oct 2022, 8:12 pm
Merck Sharp & Dohme Corp. [read post]
4 Oct 2022, 11:47 am
Merck Sharp & Dohme Corp., 2022 WL 4541687 (Fed. [read post]
1 Oct 2022, 2:31 pm
Merck Sharp & Dohme Corp., No. [read post]
29 Sep 2022, 1:15 pm
Court of Appeals for the Federal Circuit (CAFC) earlier today upheld a Patent Trial and Appeal Board (PTAB) decision finding that Mylan Pharmaceuticals, Inc. failed to show that certain claims of Merck Sharp & Dohme Corp. [read post]
